Document is current
Any future updates will be listed below
-
Authors
Perreault, Leigh https://orcid.org/0000-0002-1481-7535
Pan, Qing
Rodriguez, Carlos
Gritz, R. Mark https://orcid.org/0000-0002-2471-8741
Smith, Peter C.
Kramer, E. Seth
Tolle, Lauren
Connelly, Lauri
Tietbohl, Caroline https://orcid.org/0000-0002-9540-3050
Williams, Johnny II https://orcid.org/0009-0007-2521-4581
Holtrop, Jodi Summers
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003, 1R18DK127003)
- License Information
-
More Information
Article History
Received: 4 July 2025
Accepted: 7 October 2025
First Online: 11 December 2025
Competing interests
: L.P. has received personal fees for consulting and/or speaking from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Ascendis. The other authors declare no competing interests.
